Mojca Jarc Sojč

Every year, on 12 November, we observe World Pneumonia Day. According to the World Health Organization, pneumonia is the leading cause of death among children. Over 90 per cent of pneumonia-related child deaths occur in developing countries. Pneumonia also frequently affects the elderly, individuals with chronic illnesses, and those with weakened immune systems. Nearly half of the estimated 1.5 million pneumonia-related deaths among adults over the age of 50 are attributed to air pollution and smoking.

Pneumonia is an inflammation of lung tissue, specifically the parenchyma. The causes of community-acquired pneumonia can include viruses, especially in children under two years old, bacteria, and atypical bacteria such as Mycoplasma pneumoniae. Based on examination, it can be challenging to distinguish between different types of pathogens, as clinical symptoms may be similar across various causes: elevated body temperature, rapid breathing, cough, and fatigue.

To facilitate the identification of pneumonia pathogens, various molecular methods are now available in addition to classical techniques. These methods allow for rapid diagnosis and the prescription of appropriate therapy, which also helps reduce antibiotic resistance.

At Mikro+Polo, we recognise the importance of rapid diagnostics in treating pneumonia. This is why we have been collaborating with bioMérieux for over 30 years and utilise their Pneumonia Panel for identifying pneumonia-causing pathogens. This panel enables the detection of pathogens and antibiotic resistance genes in approximately one hour.

More about pneumonia in the video.